Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis

Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis

(2010) Suphansa Sawamiphak et al.   NATURE

Chronic DLL4 blockade induces vascular neoplasms

(2010) Minhong Yan et al.   NATURE

Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis

(2010) Yingdi Wang et al.   NATURE

Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade

(2009) S. Yamanda et al.   BLOOD

KSHV-induced notch components render endothelial and mural cell characteristics and cell survival

(2009) R. Liu et al.   BLOOD

NOTCH3 Expression Is Induced in Mural Cells Through an Autoregulatory Loop That Requires Endothelial-Expressed JAGGED1

(2009) Hua Liu et al.   CIRCULATION RESEARCH

RGS5, a Hypoxia-inducible Apoptotic Stimulator in Endothelial Cells

(2009) Yi Jin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade

(2008) J. S. Scehnet et al.   BLOOD

Development of targeted angiogenic medicine

(2008) S. LOGES et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

(2008) Juliana Hamzah et al.   NATURE